MT

Min Teng

AB AbbVie: 5 patents #4 of 70Top 6%
AP Agouron Pharmaceuticals: 1 patents #32 of 82Top 40%
NA Novo Nordisk A/S: 1 patents #26 of 131Top 20%
📍 San Diego, CA: #12 of 1,748 inventorsTop 1%
🗺 California: #353 of 28,521 inventorsTop 2%
Overall (2003): #2,882 of 273,478Top 2%
8
Patents 2003

Issued Patents 2003

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
6660755 Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity Tae K. Song, Roshantha A. Chandraratna 2003-12-09
6653483 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity Alan T. Johnson, Vidyasagar Vuligonda, Richard L. Beard, Samuel J. Gillett, Tien T. Duong +1 more 2003-11-25
6613942 Glucagon antagonists/inverse agonists Anthony Lai Ling, Vlad Edward Gregor, Javier Gonzalez, Yufeng Hong, Dan Kiel +12 more 2003-09-02
6610744 Methods of treatment with compounds having RAR&agr; receptor specific or selective activity Tien T. Duong, Roshantha A. Chandraratna 2003-08-26
6555690 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity Alan T. Johnson, Vidyasagar Vuligonda, Richard L. Beard, Samuel J. Gillett, Tien T. Duong +1 more 2003-04-29
6534544 Methods of treatment with compounds having RAR&agr; receptor specific or selective activity Tien T. Duong, Roshantha A. Chandraratna 2003-03-18
6534524 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use Robert Steven Kania, Steven Bender, Allen Borchardt, Stephan Cripps, Ye Hua +10 more 2003-03-18
6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities Elliott S. Klein, Alan T. Johnson, Andrew M. Standeven, Richard L. Beard, Samuel J. Gillett +4 more 2003-02-18